Jpmorgan Chase & CO Augmedix, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Augmedix, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 6,573 shares of AUGX stock, worth $15,380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,573
Previous 49,231
86.65%
Holding current value
$15,380
Previous $201,000
97.51%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding AUGX
# of Institutions
60Shares Held
39.6MCall Options Held
19.6KPut Options Held
15K-
Redmile Group, LLC San Francisco, CA16.4MShares$38.3 Million0.94% of portfolio
-
Dcm International Vi, Ltd.4.17MShares$9.76 Million5.31% of portfolio
-
Samjo Capital LLC2.91MShares$6.81 Million5.93% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.85MShares$4.33 Million0.0% of portfolio
-
Perkins Capital Management Inc1.42MShares$3.32 Million1.23% of portfolio
About Augmedix, Inc.
- Ticker AUGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,421,200
- Market Cap $87.6M
- Description
- Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live and Augmedix Notes solutions that provide pre-visit documentation, such as pre-charting and digitization of previous records/patient history; during-visit documentation, including medical notes...